Cytological analysis of and strategy for retarded nerve regeneration in aging animals

衰老动物神经再生迟缓的细胞学分析和策略

基本信息

  • 批准号:
    05834012
  • 负责人:
  • 金额:
    $ 1.41万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
  • 财政年份:
    1993
  • 资助国家:
    日本
  • 起止时间:
    1993 至 1994
  • 项目状态:
    已结题

项目摘要

Although regeneration of myelinated fibers after nerve-crush was shown to be retarded in aging animals, the factors of this retardation remains to be determined. To test the hypothesis that Schwann cell dysfunction with aging process was at least in part responsible for the retarded response, we investigated proliferative responses of Schwann cells in the mouse sciatic nerves after nerve-transection at 2 and 24-29 months of age. As assessed by thymidine incorporation for 24h in culture (Komiyama and Suzuki, 1992a, 1994), Schwann cells from young adult nerves proliferated rapidly within day 1 post-transection and reached a peak at day 3. However, division rate of Schwann cells from aging mouse remained at the level about one tenth of Schwann cells from young adult mouse. The number of macrophages recruited in the distal stump was also smaller in the aging nerves than in the young adult nerves. When Schwann cells from the sciatic nerves of aging mouse were maintained in the media supplemented with 15% FBS,the rate of proliferation reached one half of that of young adult mouse during an 8 day period in culture. The results of our study suggest that Schwann cell proliferation is impaired in the injured nerves of aging mouse partly because of their limited capacity to proliferate. This difference in vivo and in vitro proliferative capacity of Schwann cells may be related to the paucity of macrophage migration in the endoneural space of injured nerves of aging mice.
虽然有髓神经纤维再生后,神经压榨显示出延迟在老龄动物,这种延迟的因素仍有待确定。为了验证许旺细胞功能障碍与衰老过程中至少部分负责反应迟缓的假设,我们研究了神经横断后,在2个月和24-29个月的年龄在小鼠坐骨神经中的许旺细胞的增殖反应。通过在培养物中掺入胸苷24小时进行评估(Komiyama和Suzuki,1992 a,1994),来自年轻成人神经的许旺细胞在横断后第1天内迅速增殖,并在第3天达到峰值。而老年小鼠雪旺细胞的分裂率仅为青年小鼠雪旺细胞的十分之一左右。老化神经远端残端中招募的巨噬细胞数量也比年轻成人神经中的少。从老年小鼠坐骨神经分离的雪旺细胞在添加15%FBS的培养基中培养8天,其增殖率可达青年小鼠的一半。我们的研究结果表明,雪旺细胞增殖受损的损伤神经的老化小鼠的部分原因是因为他们的有限的增殖能力。雪旺细胞在体内和体外增殖能力的差异可能与衰老小鼠损伤神经的神经内膜间隙中巨噬细胞迁移的缺乏有关。

项目成果

期刊论文数量(42)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Komiyama A: "Progressive dystunction of twitcher schwann cells is better evaluated in vitro than in vivo" Brain Research. (in press).
小宫山 A:“抽搐雪旺细胞的进行性功能障碍在体外比在体内得到更好的评估”大脑研究。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Kamo I,Kunishita T,Kikuchi A,Nonaka I,Komiyama A: "Characterization of macrophage lineage colony stimulating factor produced by thymic myoid cells" Immunology. 79. 103-106 (1993)
Kamo I、Kunishita T、Kikuchi A、Nonaka I、Komiyama A:“胸腺肌样细胞产生的巨噬细胞谱系集落刺激因子的表征”免疫学。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Komiyama A,Suzuki K,Horie H,Hasegawa O,Kubota A: "Depressed rate of Schwann cell proliferation in aging mouse during Wallerian degeneration" Brain Pathol. 4. 571 (1994)
小宫山 A、铃木 K、堀江 H、长谷川 O、久保田 A:“沃勒变性期间衰老小鼠雪旺细胞增殖率下降”脑病理学。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Komiyama A: "Peripheral nerve toxicity" Tanaka Shobundo(in press), (1994)
小宫山 A:“周围神经毒性”田中书文堂(出版中),(1994 年)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Ohno M: "MHC Class II antigen expression and T-cell intiltration in the demyelinating CNS and PNS of the twitcher mouse" Brain Res. 625. 186-196 (1993)
Ohno M:“抽搐小鼠脱髓鞘 CNS 和 PNS 中 MHC II 类抗原表达和 T 细胞浸润”Brain Res。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KOMIYAMA Atsushi其他文献

KOMIYAMA Atsushi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KOMIYAMA Atsushi', 18)}}的其他基金

Analysis of primary immunodeficiency syndrome with low levels of antibody: diagnosis and treatment
原发性免疫缺陷综合征低抗体分析:诊断与治疗
  • 批准号:
    13470162
  • 财政年份:
    2001
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Analysis of gene defects related to NK cell deficiency : Establishment of the disorder as a new immunodeficiency
与 NK 细胞缺陷相关的基因缺陷分析:确立该疾病为新的免疫缺陷
  • 批准号:
    08457222
  • 财政年份:
    1996
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Studies on causative gene defects in primary neutrophil abnormalities with a purpose of applying it to the gene therapy
原发性中性粒细胞异常致病基因缺陷的研究及其应用于基因治疗的目的
  • 批准号:
    06454299
  • 财政年份:
    1994
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)
Establishment of hemopoietic cytokine therapy with a combination of hemopoietic factors for thrombocytopenia of childhood
造血因子联合治疗儿童血小板减少症的造血细胞因子疗法的建立
  • 批准号:
    04454277
  • 财政年份:
    1992
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)
Establishment of hematopoietic cytokine therapy with a combination of hematopoietic factors for hematologic diseases of childhood
造血因子联合治疗儿童血液病的造血细胞因子疗法的建立
  • 批准号:
    02454269
  • 财政年份:
    1990
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)
Establishment of hemopoietic cytokine therapy for chronic neutropenia of childhood based on its pathogenic mechanism.
根据儿童慢性中性粒细胞减少症发病机制建立造血细胞因子治疗方法。
  • 批准号:
    63480236
  • 财政年份:
    1988
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)

相似海外基金

Novel growth factors and regenerative RGC subtypes for optic nerve regeneration
用于视神经再生的新型生长因子和再生 RGC 亚型
  • 批准号:
    10666784
  • 财政年份:
    2023
  • 资助金额:
    $ 1.41万
  • 项目类别:
Targeting the microtubule cytoskeleton to promote cavernous nerve regeneration and erectile function after injury
靶向微管细胞骨架促进损伤后海绵体神经再生和勃起功能
  • 批准号:
    10719124
  • 财政年份:
    2023
  • 资助金额:
    $ 1.41万
  • 项目类别:
Ectopic Olfactory Receptor Guided Facial Nerve Regeneration
异位嗅觉受体引导面神经再生
  • 批准号:
    10575837
  • 财政年份:
    2023
  • 资助金额:
    $ 1.41万
  • 项目类别:
Development of optimal nerve suture method not interfere with nerve regeneration after nerve repair surgery
开发最佳神经缝合方法,不干扰神经修复手术后的神经再生
  • 批准号:
    23K15625
  • 财政年份:
    2023
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Basic research for nerve regeneration using novel functional peptide loaded artificial nerve
新型功能肽负载人工神经神经再生的基础研究
  • 批准号:
    23K09098
  • 财政年份:
    2023
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Axon Regeneration-Associated Gene Enhancers Promoting Successful CNS Nerve Regeneration
轴突再生相关基因增强剂促进中枢神经系统神经再生成功
  • 批准号:
    10511016
  • 财政年份:
    2023
  • 资助金额:
    $ 1.41万
  • 项目类别:
The role of Taf7l and Fscn1 in peripheral nerve regeneration
Taf7l和Fscn1在周围神经再生中的作用
  • 批准号:
    23K08674
  • 财政年份:
    2023
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of biofunctionalised graphene nerve conduits (NerveGraft) for nerve regeneration
开发用于神经再生的生物功能化石墨烯神经导管(NerveGraft)
  • 批准号:
    10072550
  • 财政年份:
    2023
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Collaborative R&D
Regulation of successful optic nerve regeneration by the mevalonate/cholesterol pathway
甲羟戊酸/胆固醇途径成功调节视神经再生
  • 批准号:
    10500994
  • 财政年份:
    2022
  • 资助金额:
    $ 1.41万
  • 项目类别:
Multiple approaches for optic nerve regeneration in rat optic nerve crush models
大鼠视神经挤压模型中视神经再生的多种方法
  • 批准号:
    22K09829
  • 财政年份:
    2022
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了